WITHUS PHARMACEUTICAL Co.,LTD. (KOSDAQ:330350)
South Korea flag South Korea · Delayed Price · Currency is KRW
8,390.00
+250.00 (3.07%)
At close: Apr 1, 2026

KOSDAQ:330350 Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
106,444102,72280,11964,68057,419
Other Revenue
---0--
106,444102,72280,11964,68057,419
Revenue Growth (YoY)
3.62%28.21%23.87%12.65%7.51%
Cost of Revenue
37,61437,16831,48126,34523,894
Gross Profit
68,83065,55448,63838,33533,525
Selling, General & Admin
58,71956,00237,23729,76726,100
Research & Development
2,5882,2971,8682,3571,420
Amortization of Goodwill & Intangibles
1,3371,194956.43576.93184.34
Other Operating Expenses
192.95178.61186.67278.07296.44
Operating Expenses
63,16859,89340,72933,45728,639
Operating Income
5,6635,6617,9094,8784,886
Interest Expense
-714.66-814.08-596.06-390.74-323.96
Interest & Investment Income
611.18486.88727.19468.62392.66
Currency Exchange Gain (Loss)
0.91-3.181.720.63-3.98
Other Non Operating Income (Expenses)
1,122147.77-425.51-435.03-305.14
EBT Excluding Unusual Items
6,6825,4787,6174,5214,646
Gain (Loss) on Sale of Investments
-348.82-133.971,515-373.86979.32
Gain (Loss) on Sale of Assets
--9.0410.78-385
Asset Writedown
-1,819-205---
Pretax Income
4,5145,1399,1414,1585,240
Income Tax Expense
-452.76354.31,1821,679976.07
Net Income
4,9674,7857,9592,4794,264
Net Income to Common
4,9674,7857,9592,4794,264
Net Income Growth
3.81%-39.88%221.04%-41.86%-35.91%
Shares Outstanding (Basic)
1313131313
Shares Outstanding (Diluted)
1313131313
Shares Change (YoY)
-0.05%0.21%0.03%-0.10%59.55%
EPS (Basic)
376.00362.00603.41188.00323.00
EPS (Diluted)
376.00362.00603.41188.00323.00
EPS Growth
3.87%-40.01%220.96%-41.80%-59.83%
Free Cash Flow
5,4837,268-12,044-9,9521,354
Free Cash Flow Per Share
415.06549.86-913.07-754.70102.59
Gross Margin
64.66%63.82%60.71%59.27%58.39%
Operating Margin
5.32%5.51%9.87%7.54%8.51%
Profit Margin
4.67%4.66%9.93%3.83%7.43%
Free Cash Flow Margin
5.15%7.07%-15.03%-15.39%2.36%
EBITDA
9,7469,43810,7546,8266,387
EBITDA Margin
9.16%9.19%13.42%10.55%11.12%
D&A For EBITDA
4,0843,7782,8441,9481,501
EBIT
5,6635,6617,9094,8784,886
EBIT Margin
5.32%5.51%9.87%7.54%8.51%
Effective Tax Rate
-6.89%12.93%40.38%18.63%
Advertising Expenses
830.46832.52841.87831.45887
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.